New oral anticoagulants: just a new therapeutic option or a real breakthrough?

Giancarlo Agnelli; Cecilia Becattini

doi:10.1007/s11739-009-0327-3

Related publications

Article2021

Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?

Zarrin Banikazemi, Seyed Mohammad Ali Mirazimi, Fatemeh Dashti, Mohammad Reza Mazandaranian, Maryam Akbari, Korosh Morshedi, Fatemeh Aslanbeigi, Amir Rashidian, Mohsen Chamanara, Michael R Hamblin, Mohsen Taghizadeh, Hamed Mirzaei

Article2016

Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life

Cecilia Becattini, Laura Franco, Jan Beyer‐Westendorf, Luca Masotti, Cinzia Nitti, Simone Vanni, Giorgia Manina, Sergio Cattinelli, Roberto Cappelli, Rodolfo Sbrojavacca, Fulvio Pomero, Sandra Marten, Giancarlo Agnelli

Article2023

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study

Shin-Huei Liu, Yi‐Hsin Chan, Jo‐Nan Liao, Tzeng‐Ji Chen, Professor Gregory Lip, Shih-Ann Chen

Article2013

New oral anticoagulants for the treatment of venous thromboembolism

Giancarlo Agnelli, Cecilia Becattini, Laura Franco

Article2016

Determinants of Time in Therapeutic Range in Patients Receiving Oral Anticoagulants (A Substudy of IMPACT)

Professor Gregory Lip, Albert L. Waldo, James E. Ip, David T. Martin, Malcolm Bersohn, Wassim Choucair, Joseph G. Akar, Mark S. Wathen, Jonathan L. Halperin